Noninvasive Traumatic Brain Injury Diagnostic Equipment Market is expected to reach US$ 3.541 billion by 2030

Publisher: The Insight Partners

Imaging for Device Type Segment to Hold Significant Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share During 2022–2030  

According to our latest study on "Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Forecast to 2030 – Global Analysis – Technique, Device Type, and End User," the market is expected to reach US$  3.541 billion by 2030 from US$ 1.349 billion in 2022. The report emphasizes the key factors driving the market and prominent players' developments.  

Growth Drivers:

Quick and Effective Diagnosis for TBI Patients Drives Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Growth

The main hurdle for the recovery of TBI is that it is often left undiagnosed or misdiagnosed. In the past, concussions and TBIs were diagnosed through diagnostic equipment such as computed tomography (CT) scans and other neurological examinations. However, the use of CT can increase the risk of cancer due to radiation exposure. Therefore, a prompt and accurate brain injury diagnosis is of utmost importance to address mild to severe brain injuries. In October 2023, the Biomedical Advanced Research and Development Authority (BARDA) announced a collaboration with GE Healthcare to develop a novel artificial intelligence (AI)-augmented ultrasound technology to promote rapid diagnosis of traumatic injuries. Also, BARDA will support GE Healthcare in the development of a portable ultrasound system to enhance disaster preparedness with fast response for trauma care during mass casualty incidents. Therefore, advancements in technologies are expected to bring in new noninvasive traumatic brain injury diagnostic equipment market trends in the coming years.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00038985

Report Segmentation

The “noninvasive traumatic brain injury diagnostic equipment market analysis” has been carried out by considering the following segments: technique, device type, and end user.

Noninvasive Traumatic Brain Injury Diagnostic Equipment Market, by Technique:

By technique, the noninvasive traumatic brain injury diagnostic equipment market is segmented into electroencephalography, eye tracking and near-infrared spectroscopy, magnetoencephalography, transcranial magnetic stimulation, cerebral metabolic rate of oxygen, magnetic resonance imaging, intracranial pressure, brain-computer interface, and others. The magnetic resonance imaging segment held the largest noninvasive traumatic brain injury diagnostic equipment market share in 2022. The eye tracking and near-infrared spectroscopy segment is anticipated to register the highest CAGR of 14.3% during the forecast period.

Noninvasive Traumatic Brain Injury Diagnostic Equipment Market, by Device Type:

The noninvasive traumatic brain injury diagnostic equipment market, by device type, is divided into imaging devices and monitoring devices. The imaging devices segment held a larger noninvasive traumatic brain injury diagnostic equipment market share in 2022 and monitoring devices are anticipated to register a higher CAGR of 14.5% during the forecast period. Imaging of TBI patients helps detect injuries that may require surgical or procedural intervention and determine the prognosis of patients to tailored rehabilitative therapy and counseling. According to the Journal of Nuclear Medicine 2024 report, imaging of mild TBI is generally performed using conventional techniques such as CT or MRI, which involves the monitoring of cognitive and clinical symptoms by physicians. Also, the imaging device measures the severity of TBI without conducting invasive surgery.

Manufacturers are launching innovative products to meet the growing demand for neuroimaging devices. For example, in March 2023, Abbott announced receiving the US Food and Drug Administration (USFDA) clearance for the "Alinity I laboratory instrument." This product will allow clinicians to quickly assess individuals with mild TBIs, also known as concussions.

In May 2021, GE Healthcare announced receiving the Food and Drug Administration (FDA) approval for "SIGNA 7.0T," representing GE Healthcare's strong product portfolio to advance neurological research and clinical transformation. The SIGNA 7.0T is integrated with a precision RF transmitter; its architecture enables improved image quality and research capabilities.

Noninvasive Traumatic Brain Injury Diagnostic Equipment Market, by End User:

The noninvasive traumatic brain injury diagnostic equipment market, by end user, is categorized into hospitals & clinics, diagnostic centers, and others. The hospitals & clinics segment held the largest noninvasive traumatic brain injury diagnostic equipment market share in 2022 and diagnostic centers are anticipated to register the highest CAGR of 13.4% during the forecast period. A TBI clinic is an outpatient service that provides consultation and management for individuals suffering from mild to moderate TBI. For example, Cleveland Clinic (a trusted healthcare leader recognized in the US and globally for expertise and care to treat neurological diseases) intends to treat all kinds of TBIs, from concussions to severe TBIs occurring due to falls, accidents, and other mishaps.

TBI hospitals include specialized departments offering coordinated treatment options to manage epilepsy and monitor adult and pediatric patients with regular video EEG seizure monitoring. This specialized department in hospitals provides diversified treatment options for adults and children suffering from movement disorders such as Parkinson's disease, tremors, and dystonia. The department uses a multidisciplinary approach to work closely with imaging technologies such as MRI, as well as rehabilitation and pain management.

Noninvasive Traumatic Brain Injury Diagnostic Equipment Market, by Geography:

The scope of the noninvasive traumatic brain injury diagnostic equipment market report entails North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Asia Pacific is expected to record the highest CAGR of the noninvasive traumatic brain injury diagnostic equipment market during the forecast period. China accounts for the largest noninvasive traumatic brain injury diagnostic equipment market share of the noninvasive traumatic brain injury diagnostic equipment market. According to the LANCET Neurology report, TBI is among the major public health concerns in China due to the frequency of cases registered. For instance, population-based mortality due to TBI in China is estimated to be ~13 cases per 100,000 people. This is mainly due to road traffic accidents. In response to address the concern, medical device manufacturers are developing innovative technology-based products to comprehend brain trauma. For example, "Smart Brain Device" allows clinicians to assess the motion and deformation of the brain efficiently to detect impact-induced brain traumas. Through the simulation, medical personnel can gain a comprehensive understanding of concussions and other brain injuries.

Smart Brain Device uses advanced tools such as high-speed cameras, pressure sensors, accelerometers, and displacement sensors to precisely track and capture CSF flow and pressurization during simulations for detecting external impact. Thus, the development of such innovative diagnostic products positively influences the noninvasive traumatic brain injury diagnostic equipment market growth in China.

Besides factors driving the market, the noninvasive traumatic brain injury diagnostic equipment market report emphasizes prominent players' developments. GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, and Neurovigil Inc are among the prominent players in operating in the market.

Contact Us
Contact Person: Content Team 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com